136 related articles for article (PubMed ID: 33624111)
21. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.
Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624
[TBL] [Abstract][Full Text] [Related]
22. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology.
Pogosova N; Kotseva K; De Bacquer D; von Känel R; De Smedt D; Bruthans J; Dolzhenko M;
Eur J Prev Cardiol; 2017 Sep; 24(13):1371-1380. PubMed ID: 28534422
[TBL] [Abstract][Full Text] [Related]
23. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
Eur Heart J; 1997 Oct; 18(10):1569-82. PubMed ID: 9347267
[TBL] [Abstract][Full Text] [Related]
24. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event.
Dallongevillle J; De Bacquer D; Heidrich J; De Backer G; Prugger C; Kotseva K; Montaye M; Amouyel P;
Heart; 2010 Nov; 96(21):1744-9. PubMed ID: 20956490
[TBL] [Abstract][Full Text] [Related]
25. Secondary Prevention in Younger vs. Older Coronary Heart Disease Patients-Insights from the German Subset of the EUROASPIRE IV Survey.
Wagner M; Gelbrich G; Kircher J; Kotseva K; Wood D; Morbach C; Leyh R; Ertl G; Karmann W; Störk S; Heuschmann PU
Int J Behav Med; 2018 Jun; 25(3):283-293. PubMed ID: 29086252
[TBL] [Abstract][Full Text] [Related]
26. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.
EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Lancet; 2001 Mar; 357(9261):995-1001. PubMed ID: 11293642
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
[TBL] [Abstract][Full Text] [Related]
28. [EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey].
Tokgözoğlu L; Kayıkçıoğlu M; Altay S; Aydoğdu S; Barçın C; Bostan C; Çakmak HA; Çatakoğlu AB; Emet S; Ergene O; Kalkan AK; Kaya B; Tulunay Kaya C; Kaymaz C; Koylan N; Kültürsay H; Oğuz A; Özpelit E; Ünlü S
Turk Kardiyol Dern Ars; 2017 Mar; 45(2):134-144. PubMed ID: 28424435
[TBL] [Abstract][Full Text] [Related]
29. Suboptimal achievement of low-density lipoprotein cholesterol targets in French patients with coronary heart disease. Contemporary data from the DYSIS II ACS/CHD study.
Ferrières J; Rouyer MV; Lautsch D; Ashton V; Ambegaonkar BM; Brudi P; Gitt AK;
Arch Cardiovasc Dis; 2017 Mar; 110(3):167-178. PubMed ID: 28209375
[TBL] [Abstract][Full Text] [Related]
30. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey.
Heuschmann PU; Kircher J; Nowe T; Dittrich R; Reiner Z; Cifkova R; Malojcic B; Mayer O; Bruthans J; Wloch-Kopec D; Prugger C; Heidrich J; Keil U
Eur J Prev Cardiol; 2015 Oct; 22(10):1354-62. PubMed ID: 25139770
[TBL] [Abstract][Full Text] [Related]
31. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
[TBL] [Abstract][Full Text] [Related]
32. Alcohol consumption patterns across Europe and adherence to the European guidelines in coronary patients: Findings from the ESC-EORP EUROASPIRE V survey.
van de Luitgaarden IAT; Schrieks IC; De Bacquer D; van Oort S; Mirrakhimov EM; Pogosova N; Davletov K; Dolzhenko M; van Ballegooijen AJ; Kotseva K; Grobbee DE; Beulens JWJ;
Atherosclerosis; 2020 Nov; 313():35-42. PubMed ID: 33011551
[TBL] [Abstract][Full Text] [Related]
33. Profile and treatment of chronic coronary syndromes in European Society of Cardiology member countries: The ESC EORP CICD-LT registry.
Komajda M; Cosentino F; Ferrari R; Kerneis M; Kosmachova E; Laroche C; Maggioni AP; Rittger H; Steg PG; Szwed H; Tavazzi L; Valgimigli M; Gale CP;
Eur J Prev Cardiol; 2021 May; 28(4):432-445. PubMed ID: 33966083
[TBL] [Abstract][Full Text] [Related]
34. The use of HeartQoL in patients with coronary heart disease: Association with risk factors and European reference values. The EUROASPIRE IV study of the European Society of Cardiology.
De Smedt D; Clays E; Höfer S; Oldridge N; Kotseva K; Maggioni AP; Pogosova N; Dolzhenko M; De Bacquer D
Eur J Prev Cardiol; 2016 Jul; 23(11):1174-86. PubMed ID: 26862122
[TBL] [Abstract][Full Text] [Related]
35. Dietary measures among patients with coronary heart disease in Europe. ESC EORP Euroaspire V.
Marques-Vidal P; Jankowski P; De Bacquer D; Kotseva K;
Int J Cardiol; 2020 Mar; 302():5-14. PubMed ID: 31937454
[TBL] [Abstract][Full Text] [Related]
36. SURF - SUrvey of Risk Factor management: first report of an international audit.
Cooney M; Reiner Z; Sheu W; Ryden L; Sutter Jd; De Bacquer D; DeBacker G; Mithal A; Chung N; Lim Y; Dudina A; Reynolds A; Dunney K; Graham I; ;
Eur J Prev Cardiol; 2014 Jul; 21(7):813-22. PubMed ID: 23147276
[TBL] [Abstract][Full Text] [Related]
37. Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry.
Kerneis M; Cosentino F; Ferrari R; Georges JL; Kosmachova E; Laroche C; Maggioni AP; Rittger H; Steg PG; Maczynska J; Tavazzi L; Valgimigli M; Gale CP; Komajda M;
Eur J Prev Cardiol; 2022 Nov; 29(15):1945-1954. PubMed ID: 35653582
[TBL] [Abstract][Full Text] [Related]
38. Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys.
Ungethüm K; Wiedmann S; Wagner M; Leyh R; Ertl G; Frantz S; Geisler T; Karmann W; Prondzinsky R; Herdeg C; Noutsias M; Ludwig T; Käs J; Klocke B; Krapp J; Wood D; Kotseva K; Störk S; Heuschmann PU
Clin Res Cardiol; 2023 Feb; 112(2):285-298. PubMed ID: 36166067
[TBL] [Abstract][Full Text] [Related]
39. European Society of Cardiology: Cardiovascular Disease Statistics 2019.
Timmis A; Townsend N; Gale CP; Torbica A; Lettino M; Petersen SE; Mossialos EA; Maggioni AP; Kazakiewicz D; May HT; De Smedt D; Flather M; Zuhlke L; Beltrame JF; Huculeci R; Tavazzi L; Hindricks G; Bax J; Casadei B; Achenbach S; Wright L; Vardas P;
Eur Heart J; 2020 Jan; 41(1):12-85. PubMed ID: 31820000
[TBL] [Abstract][Full Text] [Related]
40. Gender differences in Egyptian patients hospitalized with heart failure: insights from the European Society of Cardiology Heart Failure Long-Term Registry.
Hassanein M; Abdelhamid M; Ibrahim B; Sobhy M; Nasr G; Aboleineen MW; Reda A; Farag N; Elshazly A; Abdeldayem TK; Elmesseiry F; Boshra H; Sobhy H; Elbahry A; Youssef A; Ashmawy M; Abdelmoneim A; Saleh A; Elrakshy Y; Ebeid H
ESC Heart Fail; 2018 Dec; 5(6):1159-1164. PubMed ID: 30175905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
